news_image.jpg

Obesity drug may improve wound healing in diabetics

16 Nov 2021


Research presented at the recent Society for Endocrinology annual conference in Edinburgh, suggests that an AstraZeneca drug that inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 1 may improve wound healing in type 2 diabetes patients.

Medscape